Clinical Perspective to Guide Controlled Trials for TAV in SAV, TAV in TAV, and Bicuspid AS

Monday, March 10, 2025

2:00 PM – 2:08 PM ET

Speaker(s)

Michael J. Mack, MD

Chair, Cardiovascular Servivce Line
Heart Hospital Baylor Plano
Plano, Texas, United States

Disclosure(s): Boston Scientific: Consultant (Ongoing); Edwards Lifesciences: Trial Co-PI (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Study Chair (Ongoing)

Disclosure(s):

Michael J. Mack, MD: Boston Scientific: Consultant (Ongoing); Edwards Lifesciences: Trial Co-PI (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Study Chair (Ongoing)